International Journal of Clinical Oncology（国际临床肿瘤学杂志）影响因子_期刊投稿发表

期刊简介

The International Journal of Clinical Oncology (IJCO) welcomes original research papers on all aspects of clinical oncology that report the results of novel and timely investigations. Reports on clinical trials are encouraged. Experimental studies will also be accepted if they have obvious relevance to clinical oncology. Membership in the Japan Society of Clinical Oncology is not a prerequisite for submission to the journal. Papers are received on the understanding that: their contents have not been published in whole or in part elsewhere; that they are subject to peer review by at least two referees and the Editors, and to editorial revision of the language and contents; and that the Editors are responsible for their acceptance, rejection, and order of publication.

《国际临床肿瘤学杂志》（IJCO）欢迎关于临床肿瘤学各个方面的原创研究论文，这些论文报告了新颖和及时的研究结果。鼓励临床试验报告。如果实验性研究与临床肿瘤学有明显相关性，也将被接受。日本临床肿瘤学会会员资格不是向期刊投稿的先决条件。收到文件时有一项了解：其全部或部分内容未在其他地方发表;至少由两名审稿人和编辑对稿件进行同行评审，并对稿件的语言和内容进行编辑性修改;并且编辑对其接受、拒绝和发布顺序负责。

《International Journal of Clinical Oncology》期刊已被查看：次

分区信息